Addex to move aggressively on licensing

Addex Pharmaceuticals Ltd said it is prepared to take a more opportunistic approach to out-licensing its allosteric modulator compounds- even if this means opening discussions with potential licensors for very early-stage programmes.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland